Sign in Pull a receipt

COAG

Hemab Therapeutics Holdings, Inc.

Healthcare · Biotechnology

$298.87 sample

-4.02 (-1.33%) 1D

Market cap

$1.66T

Price as of

2026-10-29

Latest filing

8-K · 2026-10-23

Alerts

8

Price$298.87 +36.83% 3M daily closessample

302.89215.39

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23SECForm 144 filed
Oct 19INSInsider sell: General Counsel
Oct 12INSInsider sell: EVP, Operations
Oct 02INSInsider sell: Chief Financial Officer
Sep 24SEC8-K filed: material event
Sep 17INSInsider sell: Chief Financial Officer
Sep 09INSInsider buy: Chief Financial Officer
Sep 04SECForm 144 filed

Sign up to see the real COAG record →

Company facts

SEC EDGAR registration

Name: Hemab Therapeutics Holdings, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -38sample, -100 to +100
Reporting currency: USD

Who is positioning in COAG

sample

Insiders: 35 insider transactions over 90 days, net selling, $574.9M
Congress: No member trades over 90 days
Institutions · 13F: 39 funds hold $41.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$36.7B +16.3% y/y

Q4 2024Q3 2026

Inventory$23.2B +20.9% y/y

Q4 2024Q3 2026

Accounts receivable$17.4B +14.1% y/y

Q4 2024Q3 2026

Total debt$43.4B +10.7% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.65T +13.4% 3M
Sample peer B: $494.4B +15.2% 3M
Sample peer C: $742.4B +14.5% 3M
Sample peer D: $1.13T +12.6% 3M
Sample peer E: $1.25T -5.1% 3M